#United States #New York #Class Action #Pomerantz LLP #Hims & Hers

Overview

Major news has surfaced regarding Hims & Hers Health, Inc. (NYSE: HIMS), a company specializing in telehealth services. The Pomerantz Law Firm recently announced a class action lawsuit against Hims & Hers, drawing attention to issues surrounding the company’s business practices. If you have experienced losses from your investment in Hims & Hers, this lawsuit may affect you.

The Lawsuit Details

The class action lawsuit raises serious allegations that Hims & Hers, along with certain officers and directors, might have been involved in securities fraud and other unlawful business practices. Investors who acquired Hims & Hers shares during a specific time frame—referred to as the Class Period—are encouraged to contact the firm for further guidance.

Prospective plaintiffs have until November 2, 2026, to take action by asking the court to appoint them as Lead Plaintiff for the class. Information can easily be accessed through the Pomerantz Law Firm’s website, including a copy of the detailed complaint.

The FTC's Involvement

Compounding the legal challenges for Hims & Hers is the Federal Trade Commission (FTC), which recently filed a lawsuit against the company. The FTC has accused Hims & Hers of sharing sensitive consumer health information with third-party advertising platforms, despite the company’s assurances of maintaining user privacy. According to the FTC's complaint, consumers were misled regarding their billing and cancellation practices and were charged for prescriptions prematurely after submitting an intake form without proper consultation with medical providers.

Stock Market Reaction

The fallout from these legal actions has been noticeable in the stock market. On July 29, 2026, in light of the FTC's accusations, Hims & Hers experienced a significant drop in its stock price, falling by 14.73%, which resulted in a closing price of $25.00 per share. Such volatility raises concerns among investors regarding the future of the company's financial health.

About Pomerantz LLP

Founded by the late Abraham L. Pomerantz, a pioneer in class action law, Pomerantz LLP is well-respected in areas concerning corporate, securities, and antitrust class litigation. With over 85 years of experience, the firm continues to advocate for victims of securities fraud and director misconduct, establishing itself as one of the leading law firms in this niche.

Next Steps for Investors

Those who have invested in Hims & Hers and feel affected by these revelations are urged to reach out to Pomerantz LLP for assistance. This may be a pivotal moment for investors as class action lawsuits serve as a platform for accountability against corporate wrongdoing.

Conclusion

Investors should remain vigilant and informed regarding their investments in Hims & Hers Health, Inc. The ongoing legal proceedings could have long-term implications on not only the company's credibility but its financial stability as well. Stay tuned for further developments as this situation unfolds.